(Englisch)
In:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
;
57
, 6
;
841-843
;
2006
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:
-
Erschienen in:CANCER CHEMOTHERAPY AND PHARMACOLOGY ; 57, 6 ; 841-843
-
Verlag:
- Neue Suche nach: SPRINGER INTERNATIONAL
-
Erscheinungsdatum:01.01.2006
-
Format / Umfang:3 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 615.58
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 615.58 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 57, Ausgabe 6
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 709
-
In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFRBalin-Gauthier, D. / Delord, J. P. / Rochaix, P. / Mallard, V. r. / Thomas, F. / Hennebelle, I. / Bugat, R. / Canal, P. / Allal, C. et al. | 2006
- 719
-
4,4′-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A-007): a topical treatment for cutaneous metastases from malignant cancersEilender, D. / LoRusso, P. / Thomas, L. / McCormick, C. / Rodgers, A. H. / Hooper, C. L. / Tornyos, K. / Krementz, E. T. / Parker, S. / Morgan, L. R. et al. | 2006
- 727
-
Phase I dose-finding study and a pharmacokinetic/pharmacodynamic analysis of the neutropenic response of intravenous diflomotecan in patients with advanced malignant tumoursTrocòniz, I. a. / Garrido, M. a. / Segura, C. / Cendrós, J. M. / Principe, P. / Peraire, C. n. / Obach, R. et al. | 2006
- 736
-
A phase I combination chemotherapy study of biweekly paclitaxel and S-1 administration in patients with advanced gastric cancerHokita, S. / Aikou, T. / Miyazono, F. / Ishigami, S. / Aridome, K. / Maenohara, S. / Saihara, T. / Suenaga, K. / Nomura, H. / Maeda, S. et al. | 2006
- 741
-
Inhibition of cytokinesis and akt phosphorylation by chaetoglobosin K in ras-transformed epithelial cellsMatesic, D. F. / Villio, K. N. / Folse, S. L. / Garcia, E. L. / Cutler, S. J. / Cutler, H. G. et al. | 2006
- 755
-
A phase I study of 3-day topotecan and cisplatin in elderly patients with small-cell lung cancerFujiwara, K. / Ueoka, H. / Kiura, K. / Tabata, M. / Takigawa, N. / Hotta, K. / Umemura, S. / Sugimoto, K. / Shibayama, T. / Kamei, H. et al. | 2006
- 761
-
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastasesLee, L. / Sharma, S. / Morgan, B. / Allegrini, P. / Schnell, C. / Brueggen, J. / Cozens, R. / Horsfield, M. / Guenther, C. / Steward, W. P. et al. | 2006
- 772
-
Long intracellular retention of 4′-thio-arabinofuranosylcytosine 5′-triphosphate as a critical factor for the anti-solid tumor activity of 4′-thio-arabinofuranosylcytosineSomeya, H. / Waud, W. R. / Parker, W. B. et al. | 2006
- 781
-
Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transportersSamimi, G. / Howell, S. B. et al. | 2006
- 789
-
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignanciesSchaar, D. / Goodell, L. / Aisner, J. / Cui, X. X. / Han, Z. T. / Chang, R. / Martin, J. / Grospe, S. / Dudek, L. / Riley, J. et al. | 2006
- 796
-
Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II studyStathopoulos, G. P. / Christodoulou, C. / Stathopoulos, J. / Skarlos, D. / Rigatos, S. K. / Giannakakis, T. / Armenaki, O. / Antoniou, D. / Athanasiadis, A. / Giamboudakis, P. et al. | 2006
- 801
-
The effect of cytostatic drug treatment on intestine-specific transcription factors Cdx2, GATA-4 and HNF-1α in miceKoning, B. A. / Lindenbergh-Kortleve, D. J. / Pieters, R. / Rings, E. H. / Büller, H. A. / Renes, I. B. / Einerhand, A. W. et al. | 2006
- 811
-
In vivo antitumor efficacy and cardiotoxicity of novel anthracycline ID6105 (11-hydroxy-aclacinomycin X, Hyrubicin)Ryu, J. S. / Lee, H. S. / Hong, Y. S. / Lee, J. J. / Sohn, U. D. / Kim, T. Y. et al. | 2006
- 819
-
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in micePress, R. R. / Buckle, T. / Beijnen, J. H. / van Tellingen, O. et al. | 2006
- 826
-
Pharmacodynamic properties of methotrexate and AminotrexateTM during weekly therapyCole, P. D. / Alcaraz, M. a. / Smith, A. K. / Tan, J. / Kamen, B. A. et al. | 2006
- 835
-
Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?Marcuello, E. / Altés, A. / Menoyo, A. / Rio, E. D. / Baiget, M. et al. | 2006
- 841
-